 |
|
Incidence of Cutaneous T-Cell Lymphoma in the United States, 1973-2002
Vincent D. Criscione, AB;
Martin A. Weinstock, MD, PhD
Arch Dermatol. 2007;143(7):854-859.
Objective To describe incidence trends for cutaneous T-cell lymphoma (CTCL) in the United States.
Design Population-based study.
Setting Data were obtained from 13 population-based cancer registries of the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute from 1973 through 2002.
Participants A total of 4783 cases of CTCL were identified for the period 1973 through 2002.
Main Outcome Measure Diagnosis of CTCL.
Results The overall annual age-adjusted incidence of CTCL was 6.4 per million persons. Annual incidence increased by 2.9 x 10–6 per decade over the study period. Incidence was higher among blacks (9.0 x 10–6) than among whites (6.1 x 10–6) and was higher among men (8.7 x 10–6) than among women (4.6 x 10–6). The racial differences in incidence decreased with age, while the sex differences increased with age and decreased over time. Substantial geographic variation in incidence was found. Incidence was correlated with high physician density, high family income, high percentage of population with a bachelor's degree or higher, and high home values. Changes in International Classification of Diseases for Oncology (ICD-O) morphologic definitions have resulted in the redistribution of the cases of CTCL among specific subclassifications.
Conclusions The continued rise in incidence of CTCL is substantial, and the cause of this increase is unknown. The racial, ethnic, sex, and geographic differences in incidence may be of etiologic importance. Changes in ICD-O definitions have made it difficult to evaluate incidence trends for subclassifications of CTCL such as mycosis fungoides. In addition, these changes resulted in the creation of ambiguous histologic codes, which may have caused coding errors. These errors along with the lack of independent verification are limitations of our study. An epidemiological investigation using population-based data is important to better understand this disorder.
Author Affiliations: Dermatoepidemiology Unit, VA Medical Center, Department of Dermatology, Rhode Island Hospital, and Departments of Dermatology and Community Health, Brown University, Providence, Rhode Island.
RELATED ARTICLE
Cutaneous T-Cell Lymphoma Epidemiology: Patients Providing the Power
Stuart R. Lessin
Arch Dermatol. 2007;143(7):916-918.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Analysis of Primary CD30+ Cutaneous Lymphoproliferative Disease and Survival From the Surveillance, Epidemiology, and End Results Database
Yu et al.
JCO 2008;26:1483-1488.
ABSTRACT
| FULL TEXT
Assessment of Delayed Reporting of Mycosis Fungoides and Sezary Syndrome in the United States
Dores et al.
Arch Dermatol 2008;144:413-414.
FULL TEXT
Cutaneous T-Cell Lymphoma Epidemiology: Patients Providing the Power
Lessin
Arch Dermatol 2007;143:916-918.
FULL TEXT
|
